iRadimed Corporation Common Stock (NASDAQ: IRMD) last traded at $87.85, up 1.35% on the session. The quote above updates while this page is open; the figures below are drawn from iRadimed Corporation Common Stock’s own filings and are restated only when a new one is published.
iRadimed Corporation Common Stock trades on NASDAQ under the ticker IRMD. Its market capitalisation is $1.12 billion.
Valuation measures for iRadimed Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.12B |
|---|---|
| Enterprise value | $1.08B |
| P/E ratio | 49.08 |
| Price / sales | 13.01 |
| Price / book | 11.04 |
| Beta | 0.64 |
Trailing-twelve-month figures tagged in iRadimed Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $86.34M |
|---|---|
| Net income (TTM) | $23.05M |
| EPS (TTM) | $1.79 |
| Gross margin | 75.86% |
| Operating margin | 31.92% |
| Return on equity | 22.66% |
| Cash | $59.08M |
Range and volume for IRMD over the past 52 weeks.
| 52-week high | $107.90 |
|---|---|
| 52-week low | $67.84 |
| Volume | 72.5K |
| Average volume | 135.0K |
| Previous close | $86.68 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.